183 related articles for article (PubMed ID: 36459568)
1. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.
Williams HL; Dias Costa A; Zhang J; Raghavan S; Winter PS; Kapner KS; Ginebaugh SP; Väyrynen SA; Väyrynen JP; Yuan C; Navia AW; Wang J; Yang A; Bosse TL; Kalekar RL; Lowder KE; Lau MC; Elganainy D; Morales-Oyarvide V; Rubinson DA; Singh H; Perez K; Cleary JM; Clancy TE; Wang J; Mancias JD; Brais LK; Hill ER; Kozak MM; Linehan DC; Dunne RF; Chang DT; Koong AC; Hezel AF; Hahn WC; Shalek AK; Aguirre AJ; Nowak JA; Wolpin BM
Cancer Res; 2023 Feb; 83(3):441-455. PubMed ID: 36459568
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
[TBL] [Abstract][Full Text] [Related]
3. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
4. GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.
O'Kane GM; Grünwald BT; Jang GH; Masoomian M; Picardo S; Grant RC; Denroche RE; Zhang A; Wang Y; Lam B; Krzyzanowski PM; Lungu IM; Bartlett JMS; Peralta M; Vyas F; Khokha R; Biagi J; Chadwick D; Ramotar S; Hutchinson S; Dodd A; Wilson JM; Notta F; Zogopoulos G; Gallinger S; Knox JJ; Fischer SE
Clin Cancer Res; 2020 Sep; 26(18):4901-4910. PubMed ID: 32156747
[TBL] [Abstract][Full Text] [Related]
5. Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.
Topham JT; Karasinska JM; Lee MKC; Csizmok V; Williamson LM; Jang GH; Denroche RE; Tsang ES; Kalloger SE; Wong HL; O'Kane GM; Moore RA; Mungall AJ; Notta F; Loree JM; Wilson JM; Bathe O; Tang PA; Goodwin R; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2021 Jan; 27(1):150-157. PubMed ID: 33051307
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
7. EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of
Patil S; Steuber B; Kopp W; Kari V; Urbach L; Wang X; Küffer S; Bohnenberger H; Spyropoulou D; Zhang Z; Versemann L; Bösherz MS; Brunner M; Gaedcke J; Ströbel P; Zhang JS; Neesse A; Ellenrieder V; Singh SK; Johnsen SA; Hessmann E
Cancer Res; 2020 Nov; 80(21):4620-4632. PubMed ID: 32907838
[TBL] [Abstract][Full Text] [Related]
8. KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment.
Carpenter ES; Kadiyala P; Elhossiny AM; Kemp SB; Li J; Steele NG; Nicolle R; Nwosu ZC; Freeman J; Dai H; Paglia D; Du W; Donahue K; Morales J; Medina-Cabrera PI; Bonilla ME; Harris L; The S; Gunchick V; Peterson N; Brown K; Mattea M; Espinoza CE; McGue J; Kabala SM; Baliira RK; Renollet NM; Mooney AG; Liu J; Bhalla S; Farida JP; Ko C; Machicado JD; Kwon RS; Wamsteker EJ; Schulman A; Anderson MA; Law R; Prabhu A; Coulombe PA; Rao A; Frankel TL; Bednar F; Shi J; Sahai V; Pasca Di Magliano M
Clin Cancer Res; 2024 Jun; 30(11):2497-2513. PubMed ID: 37851080
[TBL] [Abstract][Full Text] [Related]
9. Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
N Kalimuthu S; Wilson GW; Grant RC; Seto M; O'Kane G; Vajpeyi R; Notta F; Gallinger S; Chetty R
Gut; 2020 Feb; 69(2):317-328. PubMed ID: 31201285
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium.
Bozóky B; Fernández Moro C; Strell C; Geyer N; Heuchel RL; Löhr JM; Ernberg I; Szekely L; Gerling M; Bozóky B
Neoplasia; 2021 Dec; 23(12):1300-1306. PubMed ID: 34798385
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
[TBL] [Abstract][Full Text] [Related]
13. Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype.
Juiz N; Elkaoutari A; Bigonnet M; Gayet O; Roques J; Nicolle R; Iovanna J; Dusetti N
FASEB J; 2020 Sep; 34(9):12214-12228. PubMed ID: 32686876
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of PDAC subtype heterogeneity and therapy response.
Espinet E; Klein L; Puré E; Singh SK
Trends Cancer; 2022 Dec; 8(12):1060-1071. PubMed ID: 36117109
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.
de Santiago I; Yau C; Heij L; Middleton MR; Markowetz F; Grabsch HI; Dustin ML; Sivakumar S
Int J Cancer; 2019 Aug; 145(4):1125-1137. PubMed ID: 30720864
[TBL] [Abstract][Full Text] [Related]
18. Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.
Pitter KL; Grbovic-Huezo O; Joost S; Singhal A; Blum M; Wu K; Holm M; Ferrena A; Bhutkar A; Hudson A; Lecomte N; de Stanchina E; Chaligne R; Iacobuzio-Donahue CA; Pe'er D; Tammela T
Cancer Res; 2022 Oct; 82(19):3549-3560. PubMed ID: 35952360
[TBL] [Abstract][Full Text] [Related]
19. Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies.
Guo JA; Hoffman HI; Weekes CD; Zheng L; Ting DT; Hwang WL
Clin Cancer Res; 2021 Jul; 27(14):3825-3833. PubMed ID: 33653818
[TBL] [Abstract][Full Text] [Related]
20. Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy.
Monsurrò V; Beghelli S; Wang R; Barbi S; Coin S; Di Pasquale G; Bersani S; Castellucci M; Sorio C; Eleuteri S; Worschech A; Chiorini JA; Pederzoli P; Alter H; Marincola FM; Scarpa A
J Transl Med; 2010 Jan; 8():10. PubMed ID: 20113473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
